US trade panel reviews complaint against Biocon
Washington, March 4 (IANS) The U.S. International Trade Commission (USITC) has received a complaint alleging that biosimilar versions of the cancer drug pertuzumab imported into the United States violate U.S. trade law. Several entities of India’s largest biopharmaceutical company, Biocon, have been named as respondents. The notice was published in the Federal Register. It […]
